Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions
Randomized Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions
Fundación EPIC
200 participants
Oct 23, 2025
INTERVENTIONAL
Conditions
Summary
Clinical research with medical devices indicated in accordance with the CE marking, led by researchers, multicenter, open, prospective, randomized and controlled. Patients are randomized to treatment with a conventional balloon and then a coronary stent or to initial plaque modification with Orbital Atherectomy (OA) and then a coronary stent. To evaluate the efficacy and safety of OA in the adequate treatment with coronary stent of the calcified bifurcation lesion using angiography and optical coherence tomography (OCT).
Eligibility
Inclusion Criteria3
- Patients over 18 years of age and
- Patients with moderately or severely calcified bifurcation lesions (lateral vessel ≥ 2mm), candidates for PCI with coronary stent implantation, in whom there is the possibility of adequate clinical follow-up at 1 year and
- Patients agree to participate in the study, by signing the Informed Consent.
Exclusion Criteria9
- Patients with revascularization of the artery to be treated within 9 months prior to the index procedure.
- Patients with contraindication for the use of Orbital Atherectomy:
- Patients in cardiogenic shock.
- Patients with Thrombotic lesions.
- Patients with Vascular graft disease.
- Patients with remain vessel disease.
- Patients with severe left ventricular dysfunction.
- Patients allergic to the components of the washing serum (glide).
- Patients with life expectancy less than one year.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Percutaneous coronary intervention of a calcified bifurcation coronary lesion with balloon angioplasty followed by drug eluting stent. Selection of balloon type is at operator´s discretion. Baseline and post dilation OCT will be performed.
Percutaneous coronary intervention of a calcified bifurcation coronary lesion with Orbital Atherectomy followed by drug eluting stent. Baseline and post dilation OCT will be performed.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06736899